{
  "content": "Crossref\nPubMed\nGoogle Scholar\n3.\nChristiansen C.B., Olesen J.B., Gislason G., Lock-Hansen M., Torp-Pedersen C. Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study. BMJ Open. 2013;3:e001800.\nGoogle Scholar\n4.\nBurdett P., Lip G.Y.H. Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes. 2022;8:187-194.\nCrossref\nPubMed\nGoogle Scholar\n5.\nPastori D., Farcomeni A., Pignatelli P., Violi F., Lip G.Y. ABC (atrial fibrillation Better care) pathway and healthcare costs in atrial fibrillation: the ATHERO-AF study. Am J Med. 2019;132:856-861.\nCrossref\nPubMed\nGoogle Scholar\n6.",
  "source": "https://www.jacc.org/doi/abs/10.1016/j.jacadv.2024.101117",
  "chunk_id": "6119db74-6983-479c-881d-140635a78712",
  "similarity_score": 0.2820442318916321,
  "query": "cost effectiveness economic analysis amiodarone beta-blockers atrial fibrillation healthcare costs hospitalization reduction",
  "rank": 18,
  "title": "Incidence of all-cause, cardiovascular, and atrial fibrillation-related hospitalizations: Focus on antiarrhythmic drugs",
  "authors": "Danilo Menichelli, Pasquale Pignatelli, Tommaso Brogi, Arianna Pannunzio, Francesco Violi, Gregory Y.H. Lip, Daniele Pastori",
  "year": "2024",
  "journal": "JACC: Advances",
  "reference": "Menichelli, D., Pignatelli, P., Brogi, T., Pannunzio, A., Violi, F., Lip, G. Y. H., & Pastori, D. (2024). Incidence of all-cause, cardiovascular, and atrial fibrillation-related hospitalizations: Focus on antiarrhythmic drugs. JACC: Advances, 3(8), 297-305. https://doi.org/10.1016/j.jaccadv.2024.07.015",
  "doi": "Not available",
  "chunk_index": 28,
  "total_chunks": 40,
  "retrieved_at": "2025-07-24T21:58:16.915787"
}